Supreme Court justices appeared divided over Purdue Pharma’s bankruptcy deal Monday, questioning whether it can immunize the Sackler family from civil lawsuits for their role in the opioid crisis. Described by experts as among the most important corporate bankruptcy cases in decades, the dispute will dictate the fate of the years-in-the-making settlement and more broadly…